Naloxone Prescribing and Education in Outpatient Pain Management and Palliative Care

References

• Prescription Opioid Overdose Data [Internet]. Centers for Disease Control and Prevention. 2017. [accessed 2018 Jul 24]. https://www.cdc.gov/drugoverdose/data/overdose.html.
   Google Scholar
• Chen LH, Hedegaard H, Warner M. Drug-poisoning Deaths Involving Opioid Analgesics: United States, 1999-2011. Hyattsville, MD: National Center for Health Statistics; 2014 Sept. NCHS data brief, no. 166.
   Google Scholar
• Opioids and Substance Use [Internet]. Texas Health and Human Services. [accessed 2019 Dec 10]. http://healthdata.dshs.texas.gov/Substance/Deaths.
   Google Scholar
• Karacostas C. Scale of opioid epidemic in Texas likely obscured by bad data, experts say. The Daily Texan. 2017.
   Google Scholar
• Nahin RL. Estimates of pain prevalence and severity in adults: United States, 2012. J Pain. 2015;16(8):769–80. doi:10.1016/j.jpain.2015.05.002.
   PubMed Web of Science ®Google Scholar
• Naloxone hydrochloride [package insert]. Hospira, Inc., Lake Forest, IL; 2019.
   Google Scholar
• Bailey AM, Wermeling DP. Naloxone for Opioid Overdose Prevention: pharmacists' role in community-based practice settings. Ann Pharmacother. 2014;48(5):601–6. doi:10.1177/1060028014523730.
   PubMed Web of Science ®Google Scholar
• Tewell R, Edgerton L, Kyle E. Establishment of a pharmacist-led service for patients at high risk for opioid overdose. Am J Health Syst Pharm. 2018;75(6):376–83. doi:10.2146/ajhp170294.
   PubMed Web of Science ®Google Scholar
• Freise JE, Mccarthy EE, Guy M, Steiger S, Sheu L. Increasing naloxone co-prescription for patients on chronic opioids: a student-led initiative. J Gen Intern Med. 2018;33(6):797–8. doi:10.1007/s11606-018-4397-7.
   PubMed Web of Science ®Google Scholar
• Coffin PO, Behar E, Rowe C, Santos G-M, Coffa D, Bald M, Vittinghoff E. Nonrandomized intervention study of naloxone coprescription for primary care patients receiving long-term opioid therapy for pain. Ann Intern Med. 2016;165(4):245–52.
   PubMed Web of Science ®Google Scholar
• Green TC, Heimer R, Grau LE. Distinguishing signs of opioid overdose and indication for naloxone: An evaluation of six overdose training and naloxone distribution programs in the United States. Addiction. 2008;103(6):979–89.
   PubMed Web of Science ®Google Scholar
• Devries J, Rafie S, Polston G. Implementing an overdose education and naloxone distribution program in a health system. J Am Pharm Assoc. 2017;57(2S):S154–S60. doi:10.1016/j.japh.2017.01.002.
   Google Scholar
• Zschoche JH, Nesbit S, Murtaza U, et al. Development and implementation of procedures for outpatient naloxone prescribing at a large academic medical center. Am J Heal Pharm. 2018;75:e631–40. doi:10.2146/ajhp170759.
   Google Scholar
• Behar E, Bagnulo R, Coffin PO. Acceptability and feasibility of naloxone prescribing in primary care settings: A systematic review. Prev Med. 2018;114(May):79–87. doi:10.1016/j.ypmed.2018.06.005.
   PubMedGoogle Scholar
• Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain-United States, 2016. JAMA. 2016;315(15):1624–45. doi:10.1001/jama.2016.1464.
   PubMed Web of Science ®Google Scholar
• Takeda MY, Katzman JG, Dole E, Bennett MH, Alchbli A, Duhigg D, Yonas H. Co-prescription of naloxone as a universal precautions model for patients on chronic opioid therapy-Observational study. Subst Abus. 2016;37(4):591–6. doi:10.1080/08897077.2016.1179704.
   PubMed Web of Science ®Google Scholar
• Muir JC, Scheffey C, Young HM, Vilches AO, Davis MS, Connor SR. Opioid prescribing practices before and after initiation of palliative care in outpatients. J Pain Symptom Manage. 2013;45(6):1107–11. doi:10.1016/j.jpainsymman.2012.06.006.
   PubMed Web of Science ®Google Scholar
• Percocet (R) [package insert]. Endo Pharmaceuticals Inc., Chadds Ford, PA; 2006.
   Google Scholar
• Wulz JL, Sung H, Dugan BDA, Wensel TM, Lander R, Manzella B. The pharmacist role in the development and implementation of a naloxone prescription program in Alabama. J Am Pharm Assoc (2003). 2017;57(2S):S141–7. doi:10.1016/j.japh.2016.12.078.
   PubMedGoogle Scholar
• Zedler B, Xie L, Wang L, Joyce A, Vick C, Kariburyo F, Rajan P, Baser O, Murrelle L. Risk factors for serious prescription opioid-related toxicity or overdose among veterans health administration patients. Pain Med. 2014;15(11):1911–29. doi:10.1111/pme.12480.
   PubMed Web of Science ®Google Scholar
• Miller M, Barber CW, Leatherman S, Fonda J, Hermos JA, Cho K, Gagnon DR. Prescription opioid duration of action and the risk of unintentional overdose among patients receiving opioid therapy. JAMA Intern Med. 2015;175(4):608–15. doi:10.1001/jamainternmed.2014.8071.
   PubMed Web of Science ®Google Scholar
• Lim JK, Bratberg JP, Davis CS, Green TC, Walley AY. Prescribe to prevent: overdose prevention and naloxone rescue kits for prescribers and pharmacists. J Addict Med. 2016;10(5):300–8. doi:10.1097/ADM.0000000000000223.
   PubMed Web of Science ®Google Scholar
• Gomes T, Juurlink DN, Antoniou T, Mamdani MM, Paterson JM, van den Brink W. Gabapentin, opioids, and the risk of opioid-related death: a population-based nested case–control study. PLoS Med. 2017;14(10):e1002396.
   PubMed Web of Science ®Google Scholar
• Garg RK, Fulton-Kehoe D, Franklin GM. Patterns of opioid use and risk of opioid overdose death among medicaid patients. Med Care. 2017;55(7):661–8. doi:10.1097/MLR.0000000000000738.
   PubMed Web of Science ®Google Scholar
• Abrahamsson T, Berge J, Öjehagen A, Håkansson A. Benzodiazepine, z-drug and pregabalin prescriptions and mortality among patients in opioid maintenance treatment-A nation-wide register-based open cohort study. Drug Alcohol Depend. 2017;174:58–64. doi:10.1016/j.drugalcdep.2017.01.013.
   PubMed Web of Science ®Google Scholar
• NCCN Guidelines Panel. NCCN clinical practice guidelines in oncology: palliative care. National Comprehensive Cancer Network; 2018. Version 1.2018.
   Google Scholar